Viroblock

Viroblock

Viroblock

We develop antiviral technology. New respiratory mask traps and kills immediately more than 99.9995% of influenza H1N1.
Founded
2005
Raised
$3.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$3,600,000
Venture capital (Series C) - 2012
Team Size
2
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Viroblock makes some noise.